Funder
TPU development program Priority 2030
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry
Reference153 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics. CA Cancer J Clin 71:7–33
2. Ruigrok EAM, Van Weerden WM, Nonnekens J, De Jong M (2019) The future of PSMA-targeted radionuclide therapy: an overview of recent preclinical research. Pharmaceutics 11(11):560
3. Neels OC, Kopka K, Liolios C, Afshar-Oromieh A (2021) Radiolabeled PSMA inhibitors. Cancers 13(24):6255
4. Wang Y, Chen D, Augusto RDS, Liang J, Qin Z, Liu J, Liu Z (2022) Production review of accelerator-based medical isotopes. Molecules 27(16):5294
5. International Atomic Energy Agency (2019) Cyclotron produced radionuclides: physical characteristics and production methods. TRS-468. 468:279